Long-term effects of stem cell transplantation in heart failure;Dolgoročni učinki presaditve matičnih celic pri bolnikih s srčnim popuščanjem

Zdravniski Vestnik

Volumn 81, Issue SUPPL.2, 2012, Pages 373-383

  Vrtovec, Bojan ^a   Sever, Matjaz ^a   Domanovic, Dragoslav ^b   Lezaic, Luka ^a   Poglajen, Gregor ^a   Cernelc, Peter ^a   Haddad, François ^c   Torre Amione, Guillermo ^d  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b National Blood Transfusion Institute   (Slovenia)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Dilated cardiomyopathy; Heart failure; Stem cells

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; LOOP DIURETIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SPIRONOLACTONE;

ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CD34 SELECTION; CELL MOTILITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; INTRACORONARY BONE MARROW STEM CELL TRANSPLANTATION; INTRACORONARY INFUSION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDIAL PERFUSION IMAGING; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLOVENIA; WALKING;

EID: 84874132438     PISSN: 13180347     EISSN: 15810224     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011; 58:1095-104.
2. Yousef M, Schannwell CM, Kostering M, Zeus T, Brehm M, Strauer BE. The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 2009; 53: 2262-2269
3. Cao F, Sun D, Li C, Narsinh K, Zhao L, Li X, Feng X, Zhang J, Duan Y, Wang J, Liu D, Wang H. Long-term myocardial functional improvement afterautologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J 2009; 30: 1986-1994.
4. Assmus B, Rolf A, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Tillmanns H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Tonn T, Dimmeler S, Dill T, Zeiher AM, Schachinger V, REPAIR-AMI Investigators. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010; 3: 89-96.
5. Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomized, controlled study. Heart 2009; 95: 1983-1989.
6. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, Lippolt P, Hahn A, Fichtner S, Schaefer A, Arseniev L, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized- controlled BOOST trial. Eur Heart J 2009; 30: 2978-2984.
7. Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol. 2007; 49: 2341-9.
8. Grisar JC, Haddad F, Gomari FA, Wu JC.Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomark Med. 2011; 5: 731-44.
9. Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol. 2007; 49: 741-52.
10. Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, Reichart B, Steinbeck G, Franz WM. Circulation of CD341 progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). European Heart Journal 2007; 28: 1258-1264.
11. Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leistner D, Fichtlscherer S, Schachinger V, Tonn T, Martin H, Dimmeler S, Zeiher AM. A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow-Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated Cardiomyopathy. Circ Heart Fail. 2009; 2: 417-423.
12. Seth S, Bhargava B, Narang R, Ray R, Mohanty S, Gulati G, Kumar L, Airan B, Venugopal P; AIIMS Stem Cell Study Group. The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial a long-term follow-up study. J Am Coll Cardiol. 2010; 55: 1643-4.
13. Vrtovec B, Poglajen G, Sever M, Lezaic L, Domanovic D, Cernelc P, Haddad F, Torre- Amione G.Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J Card Fail. 2011; 17: 272-81.
14. Kaski JP, Elliott P. ESC Working Group. The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy. Herz 2007; 32: 446-51.
15. Stevenson WG, Stevenson LW, Middlekauff HR, et al. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 1993; 88: 2953-2961.
16. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, Kornowski R. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001; 37: 1726-32.
17. Ebelt H, Jungblut M, Zhang Y, Kubin T, Kostin S, Technau A, Oustanina S, Niebrügge S, Lehmann J, Werdan K, Braun T. Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells. 2007; 25: 236-44.
18. Marmont AM. New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation. Annu Rev Med. 2000; 51: 115-34.
19. Tse HF, Lau CP. Therapeutic angiogenesis with bone marrow-derived stem cells. J Cardiovasc Pharmacol Ther. 2007; 12: 89-97.
20. Roura S, Planas F, Prat-Vidal C, Leta R, Soler-Botija C, Carreras F, Llach A, Hove-Madsen L, Pons Lladó G, Farré J, Cinca J, Bayes-Genis A. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. Eur J Heart Fail. 2007; 9: 995-1002.
21. Schäfer R, Abraham D, Paulus P, Blumer R, Grimm M, Wojta J, Aharinejad S. Impaired VE- cadherin beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Circulation. 2003; 108: 1585-91.
22. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M, Tokudome T, Mori H, Miyatake K, Kitamura S. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005; 112: 1128-35.
23. Vrtovec B, Poglajen G. Modern treatment methods for heart failure Zdrav Vestn 2011; 80: 302-315.